Zylox-Tonbridge’s US$330 Million IPO and Listing on the Hong Kong Stock Exchange

Davis Polk advised Zylox-Tonbridge Medical Technology Co., Ltd., while Clifford Chance has advised Morgan Stanley, CLSA and other underwriters. Grandall Advised Zylox-Tonbridge. JunHe advised Zylox-Tonbridge. The...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here